Is norepinephrine diluted in 5% dextrose compatible with use in an Ivenx intravenous infusion pump?

Your Question Contains a Misunderstanding About Norepinephrine Compatibility

Norepinephrine diluted in 5% dextrose (D5W) is NOT incompatible with infusion pumps—in fact, the FDA-approved drug label explicitly states that norepinephrine MUST be diluted in dextrose-containing solutions before infusion. 1

What the FDA Label Actually Says

The official norepinephrine (Levophed) prescribing information is crystal clear:

• "Norepinephrine Bitartrate Injection is a concentrated, potent drug which must be diluted in dextrose containing solutions prior to infusion" 1
• Approved diluents: 5% dextrose injection OR 5% dextrose and sodium chloride injections 1
• Why dextrose is required: "These dextrose containing fluids are protection against significant loss of potency due to oxidation" 1
• What to avoid: "Administration in saline solution alone is not recommended" 1

Standard Preparation for Infusion Pumps

When using an infusion pump, the FDA label provides specific instructions 1:

• Add 4 mg norepinephrine to 250 mL of D5W (yields 16 mcg/mL concentration)
• Alternative: 1 mg in 250 mL D5W (yields 4 mcg/mL)
• Administer via infusion pump at initial rate of 30-100 mL/hr, titrated to effect

Multiple clinical guidelines confirm this practice. The 2005 anaphylaxis management guidelines describe preparing epinephrine infusions in D5W and explicitly state: "If an infusion pump is available, an alternative 1:100,000 solution of epinephrine (1 mg [1 mL] in 100 mL of saline) can be prepared" 2—demonstrating that infusion pumps are the PREFERRED method for delivering catecholamine infusions.

Chemical Stability Evidence

Research confirms norepinephrine stability in dextrose solutions:

• Norepinephrine remains chemically stable for 7 days at room temperature when diluted in D5W 3
• No significant concentration decrease occurs over this period 3
• Both 4 mcg/mL and 16 mcg/mL concentrations maintain >95% potency 3

The Real Compatibility Concerns

The actual issues with norepinephrine administration are:

1. Y-site incompatibilities with other medications when multiple drugs infuse through the same lumen 4
2. Preparation errors causing concentration inhomogeneity—proper mixing technique (like the "Bubble-Flip" method) is essential 5
3. Peripheral vs. central administration—not pump compatibility 6

Bottom Line

There is no incompatibility between norepinephrine in dextrose and infusion pumps. The opposite is true: FDA labeling mandates dextrose as the diluent, and infusion pumps are the standard delivery method for precise titration of this potent vasopressor. If someone told you norepinephrine in D5W is incompatible with pumps, they are incorrect and may be confusing this with Y-site drug incompatibilities or peripheral line concerns.